14-day Premium Trial Subscription Try For FreeTry Free
RSI low/high Values: [ 25 - 75 ]
* StockInvest.us uses dynamically calculated RSI max/min levels to determine when stock is oversold or overbought based on historical behavior.
AI Analysis of PRPH
Powered by GPT-4
Upgraded!
Stock Analysis
Risk Assessment
Trading Strategy

ProPhase Labs stock price up more than 6.52% on Wednesday
(Updated on May 08, 2024)

Hold candidate since May 08, 2024 PDF

The ProPhase Labs stock price gained 6.52% on the last trading day (Wednesday, 8th May 2024), rising from $5.06 to $5.39. During the last trading day the stock fluctuated 8.40% from a day low at $5.12 to a day high of $5.55. The price has fallen in 5 of the last 10 days but is still up by 6.52% over the past 2 weeks. Volume has increased on the last day along with the price, which is a positive technical sign, and, in total, 41 thousand more shares were traded than the day before. In total, 57 thousand shares were bought and sold for approximately $308.63 thousand.

The stock lies in the middle of a very wide and strong rising trend in the short term and a further rise within the trend is signaled. Given the current short-term trend, the stock is expected to rise 11.90% during the next 3 months and, with a 90% probability hold a price between $5.26 and $8.46 at the end of this 3-month period.

Ready to grow your portfolio? Here's your beginner's guide to opening a free brokerage account.

PRPH Signals & Forecast

A buy signal was issued from a pivot bottom point on Monday, April 29, 2024, and so far it has risen 16.92%. Further rise is indicated until a new top pivot has been found. Furthermore, there is a buy signal from the 3 month Moving Average Convergence Divergence (MACD). ProPhase Labs has increased volume and follows the last lift in the price. This is considered to be a technical positive sign as volume should follow the price-formation. Higher liquidity also reduces the general risk. Some negative signals were issued as well, and these may have some influence on the near short-term development. The ProPhase Labs stock holds a buy signal from the short-term Moving Average; at the same time, however, the long-term average holds a general sell signal. Since the longterm average is above the short-term average there is a general sell signal in the stock giving a more negative forecast for the stock. On further gains, the stock will meet resistance from the long-term Moving Average at $5.83. On a fall, the stock will find some support from the short-term average at $5.19. A break-up through the long-term average will give another buy signal, while a fall below the short-term average will add another sell signal and strengthen the general signal.

Support, Risk & Stop-loss for ProPhase Labs stock

ProPhase Labs finds support from accumulated volume at $5.26 and this level may hold a buying opportunity as an upwards reaction can be expected when the support is being tested.

This stock may move very much during the day (volatility) and with a very large prediction interval from the Bollinger Band this stock is considered to be "very high risk". During the last day, the stock moved $0.430 between high and low, or 8.40%. For the last week, the stock has had daily average volatility of 7.40%.

Our recommended stop-loss: $5.17 (-4.02%) (This stock has very high daily movements and this gives very high risk. There is a buy signal from a pivot bottom found 7 days ago.)

Trading Expectations (PRPH) For The Upcoming Trading Day Of Thursday 9th

For the upcoming trading day on Thursday, 9th we expect ProPhase Labs to open at $5.35, and during the day (based on 14 day Average True Range), to move between $4.94 and $5.84, which gives a possible trading interval of +/-$0.450 (+/-8.35%) up or down from last closing price. If ProPhase Labs takes out the full calculated possible swing range there will be an estimated 16.70% move between the lowest and the highest trading price during the day.

Since the stock is closer to the resistance from accumulated volume at $5.44 (0.93%) than the support at $5.26 (2.41%), our systems don't find the trading risk/reward intra-day attractive and any bets should be held until the stock is closer to the support level.

Earnings coming up

ProPhase Labs will release earnings BMO on Thursday, May 09, 2024.The consensus among the analysts for the expected earnings (EPS) is -$0.280. We will update the financials statements for ProPhase Labs, that can be found here as soon as the records are public. Our systems has calculated a possible swing of +/- 11.07% in the first trading day after earnings release.

Is ProPhase Labs stock A Buy?

ProPhase Labs holds several positive signals, but we still don't find these to be enough for a buy candidate. At the current level, it should be considered as a hold candidate (hold or accumulate) in this position whilst awaiting further development. We have upgraded our analysis conclusion for this stock since the last evaluation from a Sell to a Hold/Accumulate candidate.

Current score: 0.692 Hold/Accumulate Upgraded

Predicted Opening Price for ProPhase Labs of Thursday, May 9, 2024

Fair opening price May 9, 2024 Current price
$5.35 ( 0.680%) $5.39

The predicted opening price is based on yesterday's movements between high, low, and closing price.

Trading levels for PRPH

Fibonacci Support & Resistance Levels

Level Price
Resistance R3 5.78 7.30 %
R2 5.62 4.25 %
R1 5.52 2.37 %
Current price: 5.39
Support S1 5.19 -3.73 %
S2 5.09 -5.61 %
S3 4.92 -8.66 %

Accumulated Volume Support & Resistance Levels

Level Price
Resistance R3 6.40 18.74 %
R2 6.27 16.33 %
R1 5.44 0.93 %
Current price 5.39
Support S1 5.26 -2.41%
S2 4.95 -8.16%
S3 4.47 -17.07%

PRPH Dividend Payout History


# Declaration Date Ex-Date Pay Date Amount Yield
1 May 13, 2022 May 24, 2022 Jun 03, 2022 $0.300 3.05%
2 Feb 16, 2022 Feb 28, 2022 Mar 10, 2022 $0.300 4.55%
3 May 13, 2021 May 24, 2021 Jun 03, 2021 $0.300 6.04%
4 Nov 20, 2019 Dec 02, 2019 Dec 12, 2019 $0.250 11.85%
5 Dec 26, 2018 Jan 09, 2019 Jan 24, 2019 $0.250 8.25%

FAQ

What is the symbol for ProPhase Labs Stock and on which exchange is it traded?
The symbol for ProPhase Labs is PRPH and it is traded on the NASDAQ (NASDAQ Stock Exchange).

Should I buy or sell ProPhase Labs Stock?
ProPhase Labs holds several positive signals, but we still don't find these to be enough for a buy candidate. At the current level, it should be considered as a hold candidate (hold or accumulate) in this position whilst awaiting further development. We have upgraded our analysis conclusion for this stock since the last evaluation from a Sell to a Hold/Accumulate candidate.

How to buy ProPhase Labs Stock?
ProPhase Labs Stock can be purchased through just about any brokerage firm, including online brokerage services.
Click here for our free guide on how to buy ProPhase Labs Stock.

What's the current price of ProPhase Labs Stock?
As of the end of day on the May 08, 2024, the price of an ProPhase Labs (PRPH) share was $5.39.

What is the 52-week high and low for ProPhase Labs Stock?
The 52-week high for ProPhase Labs Stock is $46.28 and the 52-week low is $36.31.

What is the market capitalization of ProPhase Labs Stock?
As of the May 08, 2024, the market capitalization of ProPhase Labs is 97.264M.

When is the next earnings date for ProPhase Labs?
The upcoming earnings date for ProPhase Labs is May 09, 2024.
Click to get the best stock tips daily for free!

About ProPhase Labs

ProPhase Labs ProPhase Labs, Inc. engages in the research, development, manufacture, distribution, marketing, and sale of over the counter (OTC) consumer healthcare products and dietary supplements in the United States. The company operates in two segments, Diagnostic Services and Consumer Products. It offers a range of OTC dietary supplements, including Legendz XL for male sexual health; and Triple Edge XL, an energy and stamina booster. The company also prov... PRPH Profile

Top Fintech Company

StockInvest.us featured in The Global Fintech Index 2020 as the top Fintech company of the country.

Full report by FINDEXABLE

ROCKIT